FDA Approves Tyvaso (treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension
Links shared publicly online about this topic.
- 1,858total visits
FDA Approves Tyvaso (treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension
View full resource at drugs.com
Tags: Heart Disease, High Blood Pressure, FDA, Pulmonology
Most Recently Shared on July 31, 2009 at 3:51 am By:
FDA Approves Tyvaso (treprostinil) Inhalation Solution for Pulmonary Arterial Hypertension - http://bit.ly/w1huZ
United Therapeutics Corporation - FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension
ir.unither.com — “United Therapeutics Corporation - FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension” View full resource at ir.unither.com
Most Recently Shared on July 31, 2009 at 1:12 pm By:
Dr. Warren Rosenblum Internist, Cardiologist, Physician, and Doctor
FDA approves inhaled Treprostinil (Tyvaso) for the treatment of Pulmonary Hypertension. http://tinyurl.com/kw89ks
Tyvaso approved for pulmonary arterial hypertension (PAH) - MPR
empr.com — “The FDA has approved Tyvaso (treprostinil inhalation solution, from United Therapeutics), a prostacyclin vasodilator, for the treatment of pulmonary arterial hypertension (PAH) using the Tyvaso Inhalation System.” View full resource at empr.com
Most Recently Shared on July 30, 2009 at 8:18 pm By:
MPR News: Tyvaso approved for pulmonary arterial hypertension (PAH): The FDA has approved Tyvaso (trepr.. http://bit.ly/UGQxc
Advertisement
